03.20.24
Health Canada will allow the use of several structure-function health claims in relation to TriNutra’s Thymoquin black seed (Nigella sativa) oil.
The product license allows finished product manufacturers to use claims based on published scientific data presented to Health Canada. Such claims include that oral supplementation with ThymoQuin can be used to:
“It comes with great pleasure to announce that our patented black seed oil now has the backing of these structure-function claims for Canadian brand manufacturers,” said Morris Zelkah, CEO of TriNutra. “We are continually pushing for natural product education and ingredient differentiation through our unique growing conditions, proprietary processing, and ongoing research to ensure a more potent, stable, bioavailable and efficacious product for the end consumer.”
ThymoQuin is only patented, USP-grade, full-spectrum, cold-pressed black seed oil standardized to 3% thymoquinone and very low (<1.25%) free fatty acids. It is clinically tested to support a balanced inflammatory response, improve mitochondrial activity, including ATP production, and deliver excellent antioxidant activity and antimicrobial effects.
The product license allows finished product manufacturers to use claims based on published scientific data presented to Health Canada. Such claims include that oral supplementation with ThymoQuin can be used to:
- Help support healthy liver function
- Help support cardiovascular health
- Help support healthy glucose levels
- Help support stress relief
- Help moderate general feeling of stress
- Help support healthy gut microflora
“It comes with great pleasure to announce that our patented black seed oil now has the backing of these structure-function claims for Canadian brand manufacturers,” said Morris Zelkah, CEO of TriNutra. “We are continually pushing for natural product education and ingredient differentiation through our unique growing conditions, proprietary processing, and ongoing research to ensure a more potent, stable, bioavailable and efficacious product for the end consumer.”
ThymoQuin is only patented, USP-grade, full-spectrum, cold-pressed black seed oil standardized to 3% thymoquinone and very low (<1.25%) free fatty acids. It is clinically tested to support a balanced inflammatory response, improve mitochondrial activity, including ATP production, and deliver excellent antioxidant activity and antimicrobial effects.
